Alphenal
![]() | |
![]() | |
Systematic (IUPAC) name | |
---|---|
5-phenyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
115-43-5 ![]() |
ATC code | none |
PubChem | CID 8274 |
ChemSpider |
7975 ![]() |
UNII |
7T7L08Q9JI ![]() |
Synonyms | 5-Phenyl-5-allylbarbituric acid |
Chemical data | |
Formula | C13H12N2O3 |
Molar mass | 244.246 g/mol |
| |
| |
(verify) |
Alphenal (Alphenal, Efrodal, Prophenal, Sanudorm), also known as 5-allyl-5-phenylbarbituric acid, is a barbiturate derivative developed in the 1920s.[1] It has primarily anticonvulsant properties, and was used occasionally for the treatment of epilepsy or convulsions, although not as commonly as better known barbiturates such as phenobarbital.[2][3] [4][5]
LD50: Mouse (Oral): 280 mg/kg
References
- ↑ DE Patent 526854
- ↑ Carissimi M, Nuovi Barbiturici Alogenati. Farmaco. Ediozione scientifica. 17(6):390-413. (1962).
- ↑ Martin, J. R.; Godel, T.; Hunkeler, W.; Jenck, F.; Moreau, J.-L.; Sleight, A. J.; Widmer, U. (2000). "Psychopharmacological Agents". doi:10.1002/0471238961.1619250313011820.a01.
- ↑ Hans Brandenberger; Robert A. A. Maes (1997). Analytical Toxicology: For Clinical, Forensic, and Pharmaceutical Chemists. Walter de Gruyter. p. 348. ISBN 978-3-11-010731-9. Retrieved 19 May 2012.
- ↑ Pelayo Camps García; Santiago Vázquez Cruz; Carmen Escolano Mirón (28 January 2005). Fundamentos de síntesis de fármacos. Edicions Universitat Barcelona. p. 161. ISBN 978-84-475-2876-9. Retrieved 19 May 2012.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.